Equitable distribution of COVID-19 vaccines

Type Journal Article Author Talha Burki URL https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30949-X/abstract Volume 21 Issue 1 Pages 33-34 Publication The Lancet Infectious Diseases ISSN 1473-3099, 1474-4457 Date 00/01/2021 Extra Publisher: Elsevier PMID: 33357392 Journal Abbr The Lancet Infectious Diseases DOI 10.1016/S1473-3099(20)30949-X Library Catalog www.thelancet.com Language English Abstract The announcement of the first results of Phase 3 trials for vaccine candidates for COVID-19 opens questions on future global access to licensed vaccines. Talha Burki reports.